This is Kenneth Arrow's most-cited article. He won the Nobel Prize ...
Kenneth Arrow is is an American economist, writer, and political th...
A pareto optimal allocation is an allocation of resources in which ...
The Second Optimality Theorem basically says that if you're unsatis...
Increasing returns in production is the opposite of diminishing ret...
The divergence between private and social costs/benefits relates to...
As mentioned in this paragraph, "a great many risks are not covered...
Most of the medical care that we buy from physicians is information...
There are many non-market social institutions and also market insti...
Although there is a lot of regulation in place to monitor how docto...
In 2016, of the 4,926 community hospitals in the US, 20% were state...
Here Arrow predicts the concept of value-based care.
TH1E
AMERICAN
ECONOMIC
REVIEW
VOLUME
LIII
DECEMBER
1963
NUMBER
5
UNCERTAINTY AND THE
WELFARE
ECONOMICS OF
MEDICAL CARE
By
KENNETH J.
ARROW*
I.
Introduction:
Scope
and Method
This
paper
is an
exploratory and
tentative study of
the specific
differentia
of
medical care
as the
object of normative
economics.
It
is contended
here, on the
basis of
comparison of
obvious
characteris-
tics of the
medical-care
industry with
the norms
of
welfare
economics,
that
the
special
economic
problems of
medical care
can be
explained
as
adaptations
to
the
existence of
uncertainty in the
incidence
of dis-
ease and in
the
efficacy of
treatment.
It
should
be noted that
the subject is
the medical-care
industry,
not
health.
The
causal factors
in
health are
many,
and
the provision
of
medical
care is
only one.
Particularly at low levels
of
income,
other
commodities such as
nutrition, shelter,
clothing,
and
sanitation
may
be
much
more
significant.
It
is the
complex
of services that
center
about the
physician, private
and
group
practice,
hospitals,
and
public
health,
which I
propose
to
discuss.
The focus of
discussion will be
on
the way the
operation of
the
medical-care
industry
and
the efficacy with
which it
satisfies the needs
of
society
differ from a
norm,
if
at all. The "norm"
that
the econo-
mist usually
uses for the
purposes
of
such
comparisons
is
the
operation
of a
competitive
model,
that
is,
the
flows
of
services
that would
be
*
The
author
is
professor
of economics
at
Stanford
University. He
wishes to express
his
thanks for useful comments
to
F.
Bator,
R.
Dorfman,
V.
Fuchs,
Dr.
S.
Gilson,
R.
Kessel,
S.
Mushkin,
and
C. R.
Rorem. This
paper
was
prepared
under
the
sponsorship
of the Ford
Foundation
as
part
of
a
series of
papers
on the economics of
health,
education,
and
welfare.
942
THE
AMERICAN
ECONOMIC
REVIEW
offered and
purchased and the
prices that would
be paid for them
if
each
individual in
the market
offered or purchased
services at the
going
prices as if his
decisions had no
influence over
them, and the
going
prices were such
that the amounts
of services
which were
available
equalled the total
amounts which
other
individuals were willing
to
purchase, with no
imposed
restrictions on supply
or demand.
The interest in
the competitive
model stems
partly from
its
pre-
sumed descriptive
power and partly
from its
implications
for
economic
efficiency. In
particular, we can
state the following
well-known
prop-
osition
(First
Optimality
Theorem). If a
competitive equilibrium
exists at all, and if
all commodities
relevant to
costs or utilities are
in
fact priced in the
market, then the
equilibrium is
necessarily optimal
in
the following
precise sense (due
to V. Pareto):
There is no other
allocation of
resources to services
which will
make
all participants in
the
market better
off.
Both the
conditions of this
optimality theorem
and the definition of
optimality call for
comment. A
definition is
just
a
definition, but
when
the definiendum is
a word already
in common use
with
hWighly favor-
able
connotations,
it is clear that
we are really
trying to be
persuasive;
we are
implicitly
recommending
the achievement of
optimal states.' It
is
reasonable
enough to assert that
a change in
allocation which
makes
all
participants
better off is one
that certainly
should be made; this
is
a value
judgment, not a
descriptive proposition,
but it is a very
weak
one. From this it
follows that it is
not desirable to
put up with a
non-
optimal allocation.
But it does not
follow that if
we are at an
alloca-
tion
which is
optimal in the Pareto
sense, we should
not change to
any
other. We cannot
indeed make a
change that does
not hurt
someone;
but
we can still
desire to change
to another
allocation if the
change
makes
enough
participants better
off and by so much
that we feel that
the
injury
to
others is not enough
to offset the
benefits. Such
inter-
personal
comparisons are, of
course, value
judgments. The
change,
however, by the
previous
argument ought to be
an optimal state;
of
course there are
many possible
states, each of which
is
optimal
in the
sense here used.
However,
a
value judgment on
the desirability of
each possible new
distribution
of
benefits and
costs
corresponding
to each possible
re-
allocation
of
resources is not, in
general,
necessary. Judgments
about
the distribution
can
be made
separately,
in
one
sense, from those about
allocation
if
certain conditions
are fulfilled.
Before
stating the relevant
proposition,
it is
necessary
to
remark that the
competitive equilibrium
achieved
depends
in
good measure on the
initial
distribution of pur-
chasing power, which
consists
of
ownership
of
assets
and
skills
that
'This
point has
been
stressed by I.
M. D.
Little [19, pp.
71-74].
For the
concept of a
"persuasive
definition," see C.
L.
Stevenson [27,
pp. 210-17].
ARROW:
UNCERTAINTY AND
MEDICAL CARE
943
command a
price
on
the market.
A
transfer of
assets
among individ-
uals
will,
in
general,
change the
final
supplies
of
goods
and
services
and the
prices
paid
for
them.
Thus,
a
transfer of
purchasing power
from
the well to
the
ill
will
increase the
demand for medical
services.
This
will
manifest
itself in
the
short run in
an increase
in
the
price
of
medical
services
and
in
the long
run
in an
increase
in
the
amount
sup-
plied.
With
this in
mind,
the
following statement
can be made
(Second
Optimality
Theorem): If
there
are no
increasing returns
in
production,
and if
certain
other
minor
conditions
are
satisfied,
then
every
optimal
state
is
a
competitive
equilibrium
corresponding
to some initial dis-
tribution of
purchasing
power.
Operationally, the
significance
of this
proposition is
that
if the
conditions of
the
two
optimality
theorems are
satisfied,
and if
the
allocation
mechanism
in
the
real
world
satisfies the
conditions for
a
competitive
model,
then
social
policy can
confine
itself
to
steps
taken
to
alter
the
distribution of
purchasing
power.
For
any
given
distribution
of
purchasing
power,
the
market
will,
under the
assumptions
made,
achieve a
competitive
equilibrium
which
is
neces-
sarily
optimal; and
any
optimal
state
is a
competitive
equilibrium cor-
responding to some
distribution
of
purchasing
power,
so
that
any
desired
optimal
state
can
be
achieved.
The
redistribution
of
purchasing
power
among
individuals
most
simply
takes
the form
of
money:
taxes
and
subsidies.
The
implications
of
such
a
transfer
for
individual
satisfactions
are,
in
general,
not
known in
advance.
But
we can
assume that
society can
ex post
judge
the
distribution of
satisfactions
and,
if
deemed
unsatisfactory,
take
steps
to
correct
it
by
subsequent
transfers.
Thus,
by
successive
ap-
proximations,
a
most
preferred
social
state
can
be
achieved,
with
re-
source allocation
being
handled
by
the
market
and
public
policy
con-
fined to
the
redistribution
of
money
income.2
If,
on
the
contrary, the
actual
market
differs
significantly
from
the
competitive
model,
or if
the
assumptions
of the
two
optimality
the-
orems
are not
fulfilled, the
separation
of
allocative and
distributional
procedures
becomes,
in
most
cases,
impossible.3
The
first
step
then
in the
analysis
of the
medical-care
market is the
2The
separation
between
allocation
and
distribution
even
under
the
above
assumptions
has
4osSed
over
problems
in
the execution
of
any
desired
redistribution
policy;
in
practice,
it
is
virtually
impossible
to
find a set of
taxes
and
subsidies
that
will
not
have an ad-
verse
effect on
the
achievement of
an
optimal
state.
But
this
discussion
would
take
us
even
further
afield
than
we have
already
gone.
'The
basic
theorems of
welfare
economics
alluded to
so
briefly
above
have
been
the
subject
of
voluminous
literature,
but
no
thoroughly
satisfactory
statement
covering
both
the
theorems themselves
and
the
significance of
exceptions
to them
exists. The
positive
assertions of
welfare
economics
and
their relation
to the
theory
of
competitive
equilibrium
are
admirably
covered
in
Koopmans
[181.
The
best
summary
of the
various
ways
in
which
the
theorems
can
fail
to
hold
is
probably
Bator's
[6].
944
THE
AMERICAN
ECONOMIC
REVIEW
comparison between the
actual
market
and the
competitive
model.
The
methodology
of
this
comparison
has
been
a
recurrent
subject
of
con-
troversy
in
economics
for
over a
century.
Recently, M. Friedman
[15]
has
vigorously
argued that
the
competitive
or
any
other model
should
be
tested
solely
by
its
ability to
predict.
In
the
context
of
competition,
he
comes
close to
arguing
that
prices
and
quantities are the
only
rele-
vant
data. This
point of
view
is
valuable
in
stressing
that
a
certain
amount of
lack of
realism
in
the
assumptions
of a model is
no
argu-
ment
against
its
value.
But
the
price-quantity
implications of
the com-
petitive
model
for
pricing are
not
easy to
derive without
major--and,
in
many
cases,
impossible-econometric
efforts.
In
this
paper,
the
institutional
organization
and
the
observable
mores
of
the
medical
profession are
included
among
the
data to
be
used
in
assessing the
competitiveness
of the
medical-care
market.
I shall
also
examine
the
presence
or
absence
of
the
preconditions
for
the
equiva-
lence
of
competitive
equilibria
and
optimal
states.
The
major
competi-
tive
preconditions,
in
the sense
used
here,
are
three: the
existence
of
competitive
equilibrium,
the
marketability
of
all
goods
and
services
relevant to
costs
and
utilities,
and
nonincreasing
retiurns.
The
first
two,
as
we
have
seen,
insure
that
competitive
equilibrium is
necessarily
op-
timal;
the
third insures
that every
optimal state
is the
competitive
equilibrium
corresponding
to
some
distribution
of
income.4
The
first
and
third
conditions
are
interrelated;
indeed,
nonincreasing
returns
plus
some
additional
conditions
not
restrictive
in
a
modern
economy
imply
the
existence
of a
competitive
equilibrium,
i.e.,
imply
that
there
will be
some
set
of
prices
which
will
clear all
markets.5
The
concept of
marketability
is
somewhat
broader
than
the
tradi-
tional
divergence between
private
and social
costs
and
benefits. The
latter
concept
refers
to
cases in
which
the
organization
of
the
market
does
not
require an
individual
to
pay
for
costs
that
he
imposes
on
others
as
the
result of
his
actions or
does
not
permit
him
to
receive
compensation
for
benefits he
confers. In
the
medical
field,
the
obvious
example
is
the
spread
of
communicable
diseases.
An
individual
who
fails to
be
immunized
not
only risks
his
own
health, a
disutility
which
presumably
he
has
weighed
against
the
utility
of
avoiding
the
proce-
dure,
but also
that of
others.
In
an
ideal
price
system, there
would
be a
price
which
he
would
have
to
pay
to
anyone
whose
health is
endan-
gered,
a
price
sufficiently
high
so
that the
others
would
feel
compen-
sated;
or,
alternatively,
there
would
be
a
price
which
would be
paid to
him
by others
to
induce him
to
undergo
the
immunization
procedure.
'There
are
further
minor
conditions,
for
which
see
Koopmans
[18,
pp.
50-551.
5
For
a
more
precise
statement
of
the
existence
conditions,
see
Koopmans
[18,
pp.
56-60]
or
Debreu
[12, Ch.
5] .
ARROW:
UNCERTAINTY
AND
MEDICAL CARE
945
Eilther
system
would
lead
to an
optimal
state,
though
the
distributional
implications
would
be
different. It
is, of
course,
not hard to see that
such price
systems could
not,
in
fact,
be
practical;
to
approximate
an
optimal state it
would
be
necessary
to
have
collective
intervention
in
the
form
of
subsidy
or
tax or
compulsion.
By
tlle
absence
of
marketability
for
an
action
which
is
identifiable,
technologically
possible,
and
capable of
influencing
some
individual's
welfare,
for
better
or
for
worse,
is
meant here
the
failure
of the
exist-
ing
market
to
provide a
means
whereby the
services
can
be both
of-
fered
and
demanded
upon
payment of
a
price.
Nonmarketability
may
be due
to
intrinsic
technological
characteristics
of
the
product which
prevent a
suitable
price
from
being
enforced,
as in
the
case
of com-
municable
diseases,
or it
may
be
due
to
social
or
historical
controls,
such
as
those
prohibiting
an
individual
from
selling
himself into slav-
ery.
This
distinction
is,
in
fact,
difficult to
make
precise,
though it
is
obviously
of
importance for
policy;
for
the
present
purposes,
it
will be
sufficient to
identify
nonmarketability
with
the
observed
absence
of
markets.
The
instance
of
nonmarketability
with
which
we
shall
be
most
con-
cerned is
that
of
risk-bearing.
The
relevance
of
risk-bearing to
medical
care
seems
obvious;
illness is
to a
considerable
extent
an
unpredictable
phenomenon.
The
ability
to
shift
the
risks
of
illness
to
others
is
worth
a
price
which
many
are
willing to
pay.
Because
of
pooling
and
of
supe-
rior
willingness
and
ability,
others
are
willing to
bear
the
risks.
Never-
theless,
as we
shall
see
in
greater
detail, a
great
many
risks
are
not
covered,
and
indeed
the
markets
for
the
services of
risk-coverage
are
poorly
developed
or
nonexistent.
Why
this
should be
so is
explained
in
more
detail
in
Section
IV.C
below;
briefly,
it is
impossible to
draw
up
insurance
policies
which
will
sufficiently
distinguish
among
risks,
par-
ticularly
since
observation
of
the
results
will
be
incapable of
distin-
guishing
between
avoidable
and
unavoidable
risks, so
that
incentives
to avoid losses
are
diluted.
The
optimality
theorems
discussed
above are
usually
presented
in
the literature as
referring
only
to
conditions
of
certainty,
but
there
is
no
difficulty
in
extending
them
to
the
case
of
risks,
provided
the
addi-
tional
services
of
risk-bearing
are
included
with
other
commodities.6
However,
the
variety
of
possible
risks in
the
world
is
really
stagger-
ing.
The
relevant
commodities
include,
in
effect,
bets on
all
possible
occurrences
in
the world
which
impinge
upon
utilities. In
fact,
many
of
these
"commodities,"
i.e.,
desired
protection
against
many
risks,
are
'The
theory,
in variant
forms,
seems to
have
been
first
worked
out
by
Allais
[2],
Arrow
[5],
and Baudier
[7].
For
further
generalization,
see Debreu
[11]
and
[12,
Ch.
71.
946
THE
AMERICAN ECONOMIC
REVIEW
simply not
available.
Thus,
a
wide class of commodities
is
nonmarket-
able,
and a
basic
competitive
precondition
is not
satisfied.7
There is
a
still
more
subtle
consequence
of
the
introduction of
risk-
bearing
considerations.
When
there
is
uncertainty,
information
or
knowledge
becomes
a
commodity.
Like
other
commodities,
it has
a
cost
of
production
and
a
cost
of
transmission,
and so
it
is
naturally
not
spread out over
the
entire
population
but
concentrated
among
those
who can
profit
most from
it.
(These
costs
may
be measured in time
or
disutility
as well
as
money.)
But the
demand for information is
diffi-
cult to
discuss in
the
rational terms
usually
employed.
The
value
of
information
is
frequently
not
known
in
any
meaningful
sense to
the
buyer; if,
indeed,
he
knew
enough
to
measure
the
value
of
informa-
tion, he
would
know
the
information
itself.
But
information,
in
the
form
of
skilled
care, is
precisely
what
is
being
bouight
from
most
physi-
cians,
and,
indeed, from
most
professionals.
The
elusive
character of
information
as
a
commodity
suggests
that
it
departs
considerably
from
the usual
marketability
assumptions
about
commodities.8
That risk
and
uncertainty
are,
in
fact,
significant
elements in
medi-
cal care
hardly
needs
argument.
I
will hold
that
virtually
all
the
special
features
of this
industry,
in
fact, stem
from
the
prevalence
of
uncer-
tainty.
The
nonexistence of
markets
for the
bearing
of
some
risks
in
the
first
instance
reduces
welfare
for
those
who
wish
to
transfer
those
risks
to
others
for a
certain
price, as
well
as
for
those
who
would
find it
profit-
able to
take
on
the risk
at such
prices. But it
also
reduces
the
desire to
render
or
consume
services
which
have
risky
consequences;
in
techni-
cal
language,
these
commodities are
complementary
to
risk-bearing.
Conversely,
the
production
and
consumption
of
commodities
and
serv-
ices
with
little
risk
attached
act
as
substitutes
for
risk-bearing
and
are
encouraged
by market
failure
there
with
respect to
risk-bearing.
Thus
the
observed
commodity
pattern
will
be
affected by
the
nonexistence
of
other
markets.
'
It
should
also
be
remarked
that
in
the
presence
of
uncertainty,
indivisibilities
that
are
sufficiently
small to
create
little
difficulty
for
the
existence and
viability
of
competitive
equilibrium
may
nevertheless
give
rise
to
a
considerable
range
of
increasing
returns be-
cause
of
the
operation of
the law of
large numbers.
Since most
objects of
insurance
(lives,
fire
hazards,
etc.)
have
some
element
of
indivisibility,
insurance
companies
have
to
be
above
a
certain
size. But
it is
not clear
that
this
effect is
sufficiently
great to
create
serious
obstacles
to the
existence and
viability
of
competitive
equilibrium
in
practice.
8
One form of
production
of
information
is
research.
Not
only
does
the
product
have
unconventional
aspects
as
a
commodity,
but it
is also
subject
to
increasing
returns
in
use,
since
new
ideas, once
developed,
can
be
used
over
and over
without
being
consumed, and
to
difficulties
of
market
control,
since
the cost
of
reproduction is
usually much less
than
that
of
production.
Hence,
it
is not
surprising that a
free
enterprise
economy will
tend
to
underinvest
in
research;
see Nelson
[211
and
Arrow
[4].
ARROW: UNCERTAINTY AND
MEDICAL
CARE
947
The
failure
of
one or more
of the
competitive
preconditions
has
as
its most
immediate and
obvious
consequence a
reduction in
welfare
below
that
obtainable
from
existing resources and
technology,
in
the
sense of
a failure to
reach an
optimal
state
in
the
sense of Pareto.
But
more can
be said. I
propose
here the
view that,
when the
market fails
to achieve an
optimal
state,
society will,
to
some extent at
least,
recog-
nize
the gap, and
nonmarket
social
institutions will
arise
attempting to
bridge
it.9
Certainly
this
process
is
not
necessarily
conscious;
nor is it
uniformly
successful
in
approaching
more
closely to
optimality
when
the entire
range
of
consequences
is
considered. It
has always been
a
favorite
activity
of
economists
to
point
out that
actions which
on
their
face achieve a desirable
goal
may
have
less obvious
consequences
particularly
over
time, which
more
than
offset the
original
gains.
But
it is contended here
that
the special
structural
characteristics
of the
medical-care market are
largely
attempts
to overcome
the lack
of
optimality
due
to the
nonmarketability
of
the
bearing
of
suitable risks
and the
imperfect
marketability
of
information.
These
compensatory
institutional
changes,
with
some
reinforcement from usual
profit
mo-
tives,
largely explain
the observed
noncompetitive
behavior
of
the
medical-care
market, behavior
which, in
itself,
interferes with
opti-
mality.
The
social
adjustment
towards
optimality
thus
puts obstacles
in
its own
path.
The
doctrine
that
society
will
seek
to
achieve
optimality
by
non-
market means if it
cannot achieve them in
the market is
not
novel.
Certainly,
the
government,
at least
in
its
economic
activities,
is
usually
implicitly
or
explicitly
held to
function as
the agency
which
substitutes
for the market's failure.'0
I
am
arguing
here
that in
some circum-
stances other social
institutions
will
step
into
the
optimality
gap, and
that the
medical-care
industry,
with its
variety
of
special
institutions,
some
ancient,
some
modern,
exemplifies
this
tendency.
It
may
be useful to
remark here
that a
good part
of the
preference
for
redistribution
expressed
in
government
taxation
and
expenditure
policies
and
private
charity
can
be
reinterpreted
as
desire for
insur-
ance.
It is
noteworthy
that
virtually
nowhere is
there a
system
of sub-
sidies
that has as
its
aim
simply
an
equalization
of
income.
The sub-
sidies
or other
governmental
help go
to
those
who are
disadvantaged in
life
by
events
the
incidence of
which is
popularly
regarded as
unpre-
'An
important
current
situation
in
which
normal
market
relations
have
had
to
be
greatly
modified
in the
presence of
great
risks is
the
production
and
procurement
of
modern
weapons; see
Peck
and
Scherer
[23,
pp.
581-82]
(I am
indebted
for this
refer-
ence to
V.
Fuchs)
and
[1,
pp.
71-75].
0For
an
explicit
statement
of
this
view,
see
Baumol
[8].
But I
believe
this
position
is
implicit
in
most
discussions of
the
functions of
government.
948
THE
AMERICAN
ECONOMIC
REVIEW
dictable: the
blind,
dependent
children,
the
medically
indigent.
Thus,
optimality,
in
a
context
which
includes
risk-bearing, includes
much
that
appears
to
be
motivated
by
distributional
value
judgments
when
looked
at
in
a
narrower
context."
This
methodological
background
gives
rise
to
the
following plan
for
this
paper.
Section
II
is a
catalogue
of
stylized
generalizations about
the
medical-care
market
which differentiate
it
from
the usual commod-
ity
markets.
In
Section
III
the
behavior
of
the
market
is
compared
with
that of
the
competitive
model
which
disregards the
fact of uncer-
tainty.
In
Section
IV,
the
medical-care
market is
compared,
both
as
to
behavior
and as to
preconditions,
with
the ideal
competitive
market
that
takes
account of
uncertainty;
an
attempt
will be made to
demon-
strate
that the
characteristics
outlined
in
Section
II
can be
explained
either
as the
result
of
deviations
from
the
competitive
preconditions
or
as
attempts
to
compensate
by
other
institutions
for
these
failures.
The
discussion
is
not
designed
to
be
definitive, but
provocative.
In
particu-
lar,
I
have been
chary about
drawing
policy
inferences;
to
a consider-
able
extent,
they
depend
on
further
research,
for
which
the
present
paper
is
intended to
provide
a
framework.
II. A
Survey
of
the
Special
Characteristics
of
the
Medical-Care
Market'2
This
section
will
list
selectively
some
characteristics
of
medical
care
which
distinguish
it from
the
usual
commodity of
economics
textbooks.
The list
is not
exhaustive,
and
it is
not
claimed
that
the
characteristics
listed are
individually
unique to
this
market.
But,
taken
together,
they
do
establish
a
special
place
for
medical
care
in
economic
analysis.
A.
The
Nature
of Demand
The
most
obvious
distinguishing
characteristics
of
an
individual's
demand for
medical
services
is
that
it
is
not
steady in
origin
as,
for
example,
for
food
or
clothing,
but
irregular
and
unpredictable.
Medi-
cal
services, apart
from
preventive
services,
afford
satisfaction
only
in
the
event
of
illness,
a
departure
from
the
normal
state
of
affairs. It
is
hard,
indeed,
to
think
of
another
commodity
of
significance
in
the
average
budget
of
which this
is
true.
A
portion of
legal
services,
de-
voted to
defense in
criminal
trials
or
to
lawsuits,
might
fall in
this
cate-
gory
but
the
incidence
is
surely
very
much
lower
(and,
of
course,
there
'Since
writing the
above,
I
find
that
Buchanan
and
Tullock
[10,
Ch.
13]
have
argued
that
all
redistribution can be
interpreted as
"income
insurance."
12For
an
illuminating
survey
to
which
I am
much
indebted,
see
S.
Mushkin
[20].
ARROW:
UNCERTAINTY
AND
MEDICAL CARE
949
are,
in
fact,
strong
institutional
similarities
between the
legal
and
medical-care
markets.)'3
In
addition,
the
demand
for
medical
services
is
associated,
with
a
considerable
probability,
with
an
assault
on
personal
integrity.
There
is
some risk
of
death and
a
more
considerable risk of
impairment
of
full
functioning. In
particular,
there is
a
major
potential for loss
or
reduc-
tion of
earning
ability.
The
risks
are not
by
themselves
unique;
food
is
also
a
necessity,
but
avoidance
of
deprivation
of
food can be
guaranteed
with
sufficient
income,
where
the
same
cannot be
said
of avoidance
of
illness.
Illness
is,
thus,
not
only
risky
but a
costly
risk in
itself,
apart
from
the
cost of
medical
care.
B.
Expected
Behavior
of
the
Physician
It is
clear
from
everyday
observation
that
the
behavior
expected
of
sellers
of
medical
care is
different
from
that
of
business
men in
gen-
eral.
These
expectations
are
relevant
because
medical
care
belongs to
the
category
of
commodities for
which
the
product
and the
activity
of
production
are
identical.
In all
such
cases,
the
customer
cannot
test
the
product
before
consuming it,
and
there
is
an
element
of
trust
in
the
relation.'
But
the
ethically
understood
restrictions on
the
activities
of
a
physician
are
much
more
severe
than
on
those
of,
say, a
barber. His
behavior is
supposed
to
be
governed
by
a
concern
for
the
customer's
welfare
which
would
not
be
expected
of a
salesman. In
Talcott Par-
sons's
terms,
there
is
a
"collectivity-orientation,"
which
distinguishes
medicine and
other
professions from
business,
where
self-interest
on
the
part
of
participants
is
the
accepted
norm.'5
A
few
illustrations
will
indicate
the
degree of
difference
between
the
behavior
expected of
physicians
and
that
expected of
the
typical
busi-
nessman.18
(1)
Advertising
and
overt
price
competition
are
virtually
eliminated
among
physicians.
(2) Advice
given
by
physicians
as
to
further treatment
by
himself
or
others is
supposed to
be
completely
"In
governmental
demand,
military
power
is
an
example
of
a
service
used
only
irregularly
and
unpredictably.
Here
too,
special
institutional
and
professional
relations
have
emerged,
though
the
precise
social
structure is
different for
reasons
that
are
not
hard
to
analyze.
"
Even
with
material
commodities,
testing
is
never
so
adequate
that
all
elements
of
implicit
trust can
be eliminated.
Of
course,
over
the
long
run,
experience
with the
quality
of
product
of
a
given
seller
provides
a
check on
the
possibility
of
trust.
15See
[22,
p. 463].
The whole of
[22,
Ch. 101
is a
most
illuminating
analysis
of
the
social
role of
medical
practice;
though
Parsons'
interest
lies in
different
areas
from
mine,
I
must
acknowledge
here
my
indebtedness
to
his
work.
16
I
am indebted to
Herbert Klarman
of
Johns
Hopkins
University for
some
of the
points discussed
in this
and the
following
paragraph.
950 THE AMERICAN ECONOMIC REVIEW
divorced
from
self-interest. (3) It is at least claimed that
treatment
is
dictated
by
the
objective
needs of
the case
and not
limited
by
financial
considerations."7
While the ethical compulsion is surely not
as absolute
in
fact as it
is in
theory, we can hardly suppose that it has
no influence
over
resource allocation in this area. Charity treatment in
one form
or
another does
exist because
of
this tradition about human
rights to ade-
quate medical care.'8 (4) The physician is relied on as
an expert
in
certifying
to
the existence of illnesses and injuries for various
legal
and
other
purposes. It
is
socially expected that his concern for the correct
conveying
of
information will, when appropriate, outweigh his desire
to
please
his
customers."g
Departure from the profit motive is strikingly
manifested by the
overwhelming predominance
of
nonprofit
over
proprietary
hospitals.20
The
hospital per
se offers services
not too different from
those of
a
hotel,
and it is
certainly
not obvious
that the profit motive
will not lead
to a
more efficient
supply.
The
explanation may
lie
either on the
supply
side or on
that
of
demand.
The
simplest explanation
is
that
public
and
private subsidies decrease the cost to the patient in
nonprofit hospitals.
A
second
possibility
is
that
the association of
profit-making
with the
supply
of
medical services
arouses
suspicion
and
antagonism
on
the
part
of
patients
and
referring physicians,
so
they
do
prefer
nonprofit
institutions.
Either
explanation implies
a
preference
on
the
part
of
some
group, whether
donors or
patients, against
the
profit
motive in the
supply
of
hospital
services.2'
1T The
belief that the ethics of
medicine demands treatment
independent of the patient's
ability to
pay is strongly ingrained.
Such a perceptive observer as
Rene Dubos has made
the
remark that
the
high
cost
of
anticoagulants restricts their use
and may contradict
classical
medical ethics,
as
though this
were an unprecedented
phenomenon.
See
[13,
p.
4191.
"A
time
may
come when medical
ethics will have to be
considered in the harsh
light of
economics" (emphasis added).
Of course, this expectation
amounts to ignoring
the
scarcity
of medical
resources;
one
has
only
to
have
been
poor
to
realize the error.
We
may
confidently
assume
that
price
and
income do
have some
consequences for
medical
expenditures.
18A
needed
piece
of
research
is a
study
of the
exact nature of
the
variations of medical
care
received
and medical
care
paid
for as
income
rises.
(The
relevant
income
concept
also
needs
study.)
For this
purpose,
some
disaggregation
is
needed;
differences in
hospital
care which
are essentially
matters
of
comfort
should,
in
the above
view, be much
more
responsive to
income
than, e.g., drugs.
"9 This role is
enhanced in a socialist
society,
where the
state itself is
actively concerned
with illness
in relation to
work;
see
Field
[14,
Ch.
91.
'
About
3 per
cent
of beds were
in
proprietary hospitals
in
1958, against
30 per
cent
in
voluntary
nonprofit,
and the remainder in
federal, state,
and
local
hospitals;
see
[26,
Chart
4-2,
p.
601.
"
C.
R.
Rorem
has
pointed
out
to me some
further factors
in
this
analysis. (1)
Given
the
social intention of
helping
all
patients
without
regard
to immediate
ability
to
pay,
economies
of scale would dictate a
predominance
of
community-sponsored
hospitals. (2)
ARROW:
UNCERTAINTY
AND
MEDICAL CARE
951
Conformity
to
collectivity-oriented behavior is
especially
important
since
it is a
commonplace
that
the
physician-patient relation affects
the
quality of
the
medical
care
product. A
pure cash nexus would be
in-
adequate;
if
nothing
else,
the
patient
expects
that
the same
physician
will
normally
treat
him on
successive
occasions. This
expectation
is
strong
enough
to
persist even in
the
Soviet
Union,
where
medical
care
is
nominally
removed
from
the
market
place
[14,
pp.
194-96].
That
purely
psychic
interactions
between
physician
and
patient
have
effects
which are
objectively
indistinguishable
in kind from the effects
of
medication is
evidenced
by
the
use of
the placebo as a
control in medi-
cal
experimentation;
see
Shapiro
[25].
C.
Product
Uncertainty
Uncertainty
as to
the
quality of
the
product is
perhaps
more intense
here
than in
any
other
important
commodity.
Recovery from
disease
is
as
unpredictable
as is
its
incidence.
In
most
commodities, the
possi-
bility
of
learning
from
one's
own
experience
or
that
of
others is
strong
because
there is
an
adequate
number
of
trials.
In
the
case
of severe
ill-
ness,
that is,
in
general, not
true;
the
uncertainty
due to
inexperience
is
added
to the
intrinsic
difficulty
of
prediction.
Further,
the
amount
of
uncertainty,
measured
in
terms of
utility
variability, is
certainly
much
greater
for
medical care in
severe
cases than
for, say,
houses
or
auto-
mobiles,
even
though
these are
also
expenditures
sufficiently
infre-
quent
so
that there
may
be
considerable
residual
uncertainty.
Further,
there
is a
special
quality to the
uncertainty; it
is
very dif-
ferent on
the
two sides
of
the
transaction.
Because
medical
knowledge
is
so
complicated, the
information
possessed
by the
physician as
to
the
consequences and
possibilities
of
treatment
is
necessarily
very
much
greater
than
that of
the
patient,
or at
least so
it is
believed
by
both
parties.22
Further,
both
parties
are
aware of
this
informational
inequal-
ity, and
their
relation
is
colored
by this
knowledge.
To avoid
misunderstanding,
observe
that
the
difference
in
informa-
tion
relevant
here is a
difference
in
information
as to
the
consequence
of
a
purchase of
medical
care.
There
is
always
an
inequality of
infor-
mation
as to
production
methods
between
the
producer
and
the pur-
chaser of
any
commodity,
but
in
most
cases
the
customer
may
well
Some
proprietary
hospitals will tend
to control
total
costs
to the
patient
more
closely, in-
cluding
the
fees
of
physicians,
who will
therefore
tend
to
prefer
community-sponsored
hospitals.
2"Without
trying
to
assess
the
present
situation,
it is
clear in
retrospect
that
at
some
point
in
the
past
the
actual
differential
knowledge
possessed
by
physicians
may
not
have
been
much.
But
from
the
economic
point of
view,
it is
the
subjective
belief
of
both
parties,
as
manifested
in
their
market
behavior,
that is
relevant.
952
THE
AMERICAN
ECONOMIC
REVIEW
have as
good or nearly as
good an
understanding of the utility of
the
product
as
the producer.
D.
Supply Conditions
In
competitive theory,
the supply of a
commodity is governed by
the
net
return from its
production compared
with the return
derivable
from
the use of the same
resources elsewhere.
There are several
sig-
nificant
departures from
this theory in the
case of medical care.
Most
obviouisly,
entry
to the profession is
restricted by
licensing.
Licensing,
of course,
restricts supply and
therefore increases the cost of
medical
care. It is
defended as guaranteeing
a minimum of
quality.
Restriction
of
entry by
licensing occurs in most
professions,
including
barbering
and
undertaking.
A
second
feature is
perhaps even more
remarkable. The cost
of
medical education
today is
high and, according
to the usual
figures,
is
borne
only
to a minor
extent
by the student.
Thus,
the
private
benefits
to the
entering student
considerably exceed the costs.
(It is,
however,
possible that
research
costs, not properly
chargeable
to
education,
swell the
apparent
difference.)
This
subsidy
should,
in
principle,
cause
a fall
in
the
price
of
medical
services, which,
however,
is
offset by
ra-
tioning
through
limited
entry
to
schools
and
through
elimination of
students
during
the medical-school
career.
These
restrictions
basically
render
superfluous the
licensing, except
in
regard to graduates of for-
eign
schools.
The
special
role
of
educational institutions
in
simultaneously
sub-
sidizing
and
rationing
entry
is
common to all
professions
requiring
advanced
training.23
It is a
striking
and
insufficiently
remarked
phe-
nomenon that such
an
important
part
of
resource allocation should
be
performed
by nonprofit-oriented
agencies.
Since
this
last
phenomenon
goes
well
beyond
the
purely
medical
aspect,
we
will not
dwell
on
it
longer
here
except
to note
that
the
anomaly
is
most
striking
in
the medical
field.
Educational
costs tend to
be
far
higher
there
than
in
any
other branch
of
professional
training.
While
tuition
is the
same,
or
only slightly
higher,
so
that
the
subsidy
is
much
greater,
at the same time the
earnings
of
physicians
rank
high-
est
among professional
groups,
so
there
would not
at first blush
seem
to be
any necessity
for
special
inducements to
enter
the
profession.
Even if
we
grant that,
for
reasons
unexamined
here,
there is a
social
interest
in
subsidized
professional
education,
it
is not clear
why the
rate of
subsidization should differ
among professions. One
might
ex-
23The
degree
of
subsidy
in
different
branches
of
professional
education is
worthy
of a
major
research
effort.
ARROW:
UNCERTAINTY AND
MEDICAL
CARE
953
pect
that the tuition
of
medical
students
would
be
higher
than that
of
other
students.
The
high
cost
of
medical
education
in
the
United
States is
itself
a
reflection of
the
quality
standards
imposed by
the
American
Medical
Association since
the
Flexner
Report,
and it is,
I
believe,
only
since
then
that the
subsidy element in
medical
education has
become
signifi-
cant.
Previously,
many
medical
schools
paid their
way
or even
yielded
a
profit.
Another
interesting
feature of
limitation
on
entry
to
subsidized
edu-
cation
is the
extent of
individual
preferences
concerning
the
social
welfare,
as
manifested
by
contributions
to
private
universities.
But
whether
support is
public or
private, the
important
point is
that both
the
quality
and the
quantity of
the
supply
of
medical care are
being
strongly
influenced
by
social
nonmarket forces.24'25
One
striking
consequence
of
the control of
quality
is
the
restriction
on
the
range
offered. If
many
qualities of
a
commodity are
possible, it
would
usually
happen in
a
competitive
market
that
many
qualities
will
be
offered
on
the
market,
at
suitably
varying
prices,
to
appeal to
dif-
ierent
tastes
and
incomes.
Both the
licensing
laws and
the
standards of
medical-school
training
have
limited the
possibilities of
alternative
qualities of
medical
care.
The
declining
ratio
of
physicians to
total
employees
in
the
medical-care
industry
shows
that
substitution of
less
trained
personnel,
technicians, and
the
like, is
not
prevented
com-
pletely,
but
the
central
role of
the
highly
trained
physician
is
not af-
fected
at
all.26
E.
Pricing
Practices
The
unusual
pricing
practices
and
attitudes
of the
medical
profes-
sion
are well
known:
extensive
price
discrimination by
income
(with an
extreme
of
zero
prices for
sufficiently
indigent
patients) and,
formerly,
a strong
insistence on
fee
for
services as
against
such
alternatives as
prepayment.
'Strictly
speaking,
there are four
variables
in
the
market for
physicians:
price,
quality
of
entering
students,
quality
of
education, and
quantity.
The
basic
market
forces,
demand
for
medical
services
and
supply
of
entering
students,
determine
two
relations
among
the
four
variables.
Hence, if the
nonmarket
forces
determine
the
last
two,
market
forces
will
determine
price
and
quality
of
entrants.
'The
suipply
of
Ph.D.'s is
similarly
governed,
but
there
are
other
conditions
in the
market
which
are
much
different,
especially
on
the
demand
side.
'Today
oinly
the
Soviet
Union
offers
an
alternative
lower level
of
medical
personnel,
the
feldshers,
who
practice
primarily in
the
rural
districts
(the
institution
dates
back
to the 18th
century).
According
to
Field
[14,
pp.
98-100,
132-33],
there is
clear
evidence
of strain
in
the
relations between
physicians and
feldshers,
but
it
is
not
certain
that
the
feldshers
will
gradually
disappear
as
physicians
grow in
numbers.
954
THE
AMERICAN
ECONOMIC
REVIEW
The
opposition to
prepayment is
closely
related
to
an even
stronger
opposition
to
closed-panel
practice
(contractual
arrangements
which
bind the
patient to a
particular
group
of
physicians). Again
these
atti-
tudes seem to
differentiate
professions
from
business.
Prepayment
and
closed-panel
plans
are
virtually
nonexistent
in
the
legal profession. In
ordinary
business, on
the other
hand, there exists
a wide
variety
of
exclusive
service contracts
involving sharing
of
risks;
it is
assumed
that
competition will select those which
satisfy
needs best.27
The
problems
of
implicit
and
explicit
price-fixing
should also
be
mentioned.
Price
competition
is
frowned
on.
Arrangements
of
this
type
are not
uncommon
in
service
industries,
and
they
have
not
been sub-
jected
to
antitrust
action.
How
important
this is is hard
to
assess.
It
has been
pointed
out
many times that the
apparent
rigidity of
so-called
admiriistered
prices
considerably
understates the actual
flexibility.
Here, too,
if
physicians
find
themselves with
unoccupied time,
rates are
likely to
go down,
openly
or
covertly;
if
there
is
insufficient
time for
the
demand, rates
will
surely rise.
The
"ethics" of
price
competition
may
decrease the
flexibility
of
price
responses,
but
probably
that is all.
III.
Comparisons
with
the
Competitive
Model under
Certainty
A.
Nonmarketable Commodities
As
already noted,
the diffusion
of
communicable diseases
provides
an obvious
example
of
nonmarket
interactions.
But from a
theoretical
viewpoint,
the
issues are well
understood, and
there is little
point in
expanding
on
this
theme. (This
should not be
interpreted as
minimiz-
ing
the
contribution of
public health
to welfare;
there is
every reason
to
suppose
that
it is
considerably
more important
than
all other
aspects
of medical
care.)
Beyond
this
special area
there
is a
more general
interdepeiidence,
the
concern of
individuals for the
health of
others.
The economic
manifes-
tations
of
this taste are to be
found
in
individual
donations to
hocpitals
and to
medical
education,
as
well
as
in
the
widely accepted
responsi-
bilities of
government
in this
area.
The taste for
improving the health
of others
appears
to
be
stronger
than for
improving
other
aspects
of
their
welfare.28
In
interdependencies
generated
by concern
for
the welfare
of others
there is
always
a theoretical
case
for
collective action if each
partici-
pant
derives satisfaction from
the contributions of
all.
'
The
law does
impose
some limits on
risk-shifting in
contracts, for
example, its gen-
eral
refusal to honor
exculpatory
clauses.
'
There
may be an
identification
problem in this
observation.
If the
failure of the
market
system
is, or
appears to be, greater
in medical care than
in, say,
food an
in-
dividual
otherwise equally
concerned
about
the two aspects
of others' welfare
may prefer
to
help
in
the
first.
ARROW: UNCERTAINTY
AND
MEDICAL
CARE
955
B.
Increasing
Returns
Problems
associated
with
increasing
returns
play
some role
in allo-
cation
of
resources
in the
medical field,
particularly
in areas
of low
density or
low
income.
Hospitals
show
increasing
returns
up to
a point;
specialists
and
some
medical
equipment
constitute significant indivisi-
bilities. In
many
parts of
the
world the
individual physician
may be
a
large
unit
relative
to
demand. In
such
cases it
can be
socially
desirable
to
subsidize
the
appropriate
medical-care
unit.
The
appropriate mode
of
analysis is
much
the
same as for
water-resource
projects.
Increasing
returns are
hardly
apt to
be a
significant
problem
in general
practice in
large
cities
in the
United
States,
and
improved
transportation
to
some
extent reduces
their
importance
elsewhere.
C.
Entry
The most
striking
departure from
competitive behavior is
restriction
on
entry to
the
field, as
discussed in
II.D
above. Friedman
and Kuz-
nets,
in a
detailed
examination
of the
pre-World War
II
data,
have
argued that
the higher income
of
physicians
could be
attributed
to
this
restriction.29
There is
some
evidence
that
the
demand for
admission to
medical
school has
dropped
(as
indicated by
the
number of
applicants
per
place
and the
quality of
those
admitted),
so
that the
number
of medi-
cal-school
places
is
not
as
significant a barrier
to entry as in
the
early
1950's
[28,
pp.
14-15].
But it
certainly
has
operated over
the
past and
it
is
still
operating
to a
considerable
extent
today. It
has, of
course,
constituted a
direct
and
unsubtle
restriction on
the
supply of
medical
care.
There are several
considerations
that must
be
added
to help
evaluate
the
importance
of
entry
restrictions: (1) Additional
entrants
would
be,
in
general, of
lower
quality;
hence, the
addition
to the
supply
of medi-
cal
care,
properly
adjusted
for
quality,
is
less
than
purely
quantitative
calculations
would show.30
(2)
To
achieve
genuinely
competitive con-
ditions,
it
would
be
necessary
not
only
to
remove
numerical
restrictions
on
entry
but
also
to
remove the
subsidy
in
medical
education.
Like
any
other
producer,
the
physician
should
bear
all
the costs
of
production,
"
See
[16,
pp.
118-37].
The
calculations
involve
many
assumptions
and
must
be re-
garded
as
tenuous;
see the
comments
by
C.
Reinold
Noyes
in
[16,
pp.
407-10].
'It
might
be
argued
that
the
existence
of
racial
discrimination
in
entrance has
meant
that
some of
the
rejected
applicants are
superior to
some
accepted.
However,
there is
no
necessary
connection
between an
increase in
the
number of
entrants and
a
reduction
in
racial
discrimination;
so
long
as
there is
excess
demand
for
entry,
discrimination
can
continue
unabated
and new
entrants
will
be
inferior
to
those
previously
accepted.
956
THE
AMERICAN
ECONOMIC
REVIEW
including,
in
this
case,
education.3'
It
is
not so
clear
that this
change
would
not
keep
even
unrestricted
entry down
below
the
present
level.
(3)
To
some
extent, the
effect of
making
tuition
carry
the full
cost
of
education
will
be to
create
too
few
entrants,
rather
than
too
many.
Given the
imperfections of
the
capital
market,
loans for
this
purpose
to
those who
do
not
have
the cash
are
difficult
to
obtain.
The
lender
really
has
no
security.
The
obvious
answer
is
some form
of
insured
loans,
as
has
frequently
been
argued;
not
too
much
ingenuity
would
be
needed
to
create
a
credit
system
for
medical
(and other
branches of
higher)
education.
Under
these
conditions the
cost
would still constitute
a
de-
terrent,
but
one
to be
compared
with the
high
future
incomes
to be
obtained.
If
entry
were
governed
by
ideal
competitive
conditions, it
may
be
that the
quantity
on
balance
would
be
increased,
though this conclu-
sion is
not
obvious.
The
average
quality
would
probably
fall,
even
under
an
ideal
credit
system,
since
subsidy
plus
selected
entry
draw
some
highly
qualified
individuals
who
would
otherwise
get
into
other
fields.
The
decline in
quality is
not
an
over-all
social
loss,
since
it is
accompanied
by
increase
in
quality in
other
fields of
endeavor;
indeed,
if
demands
accurately
reflected
utilities,
there
would be
a
net
social
gain
through a
switch
to
competitive
entry.32
There is a
second
aspect
of
entry
in
which
the
contrast with com-
petitive
behavior
is,
in
many
respects,
even
sharper.
It is
the
exclusion
of
many
imperfect
substitutes
for
physicians.
The
licensing
laws,
though
they
do
not
effectively
limit the
number
of
physicians, do ex-
clude
all
others
from
engaging
in
any one
of
the
activities
known
as
medical
practice. As
a
result,
costly
physician
time
may
be
employed
at
speCific
tasks for
which
only
a
small
fraction
of their
training
is
needed,
and
which
could be
performed by
others
less
well
trained
and
therefore
less
expensive.
One
might
expect
immunization
centers,
pri-
vately
operated,
but
not
necessarily
requiring
the
services of
doctors.
In
the
competitive
model
without
uncertainty,
consumers
are
pre-
siumed
to
be able
to
distinguish
qualities
of the
commodities
they
buy.
Under this
hypothesis,
licensing would
be, at
best,
superfluous
and
exclude
those
from
whom
consumers
would
not
buy
anyway;
but it
might exclude
too
many.
D.
Pricing
The
pricing practices
of
the
medical
industry
(see
II.E
above)
de-
'
One
problem here
is that
the
tax
laws do
not
permit
depreciation
of
professional
education,
so that
there
is
a
discrimination
against
this
form of
investment.
"2
To
anticipate later
discussion,
this
condition is
not
necessarily
fulfilled.
When it
comes to
quality
choices,
the
market
may be
inaccurate.
ARROW:
UNCERTAINTY
AND
MEDICAL CARE
957
part
sharply
from the
competitive
norm.
As
Kessel
[17]
has
pointed
out
with
great
vigor,
not
only is
price
discrimination
incompatible
with
the
competitive
model, but
its
preservation
in
the
face
of
the
large
number
of
physicians
is
equivalent to a
collective
monopoly.
In
the
past, the
opposition to
prepayment
plans
has taken
distinctly
coercive
forms,
certainly
transcending
market
pressures,
to say
the
least.
Kessel
has
argued
that
price
discrimination is
designed to
maximize
profits
along
the
classic
lines of
discriminating
monopoly
and that
organized
medical
opposition to
prepayment
was
motivated
by
the
desire
to
protect
these
profits.
In
principle,
prepayment
schemes
are
compatible with
discrimination,
but
in
practice they
do
not
usually
discriminate. I
do not
believe the
evidence that
the
actual scale of
dis-
crimination
is
profit-maximizing is
convincing. In
particular,
note that
for
any
monopoly,
discriminating
or
otherwise, the
elasticity
of
demand
in
each
market
at the
point
of
maximum
profits is
greater than
one.
But
it
is
almost
surely
true
for
medical
care
that the price
elasticity
of
demand for
all
income
levels is
less than
one.
That
price
discrimina-
tion
by
income
is
not
completely
profit-maximizing
is obvious
in the
extreme
case
of
charity; Kessel
argues that this
represents
an
appease-
ment of
public
opinion. But this
already
shows
the
incompleteness
of
the model
and
suggests
the
relevance
and
importance
of social and
ethical
factors.
Certainly
one
important
part
of
the
opposition
to
prepayment
was
its
close
relation
to
closed-panel
plans.
Prepayment is
a form
of
insur-
ance,
and
naturally
the
individual
physician
did
not wish to
assume the
risks.
Pooling
was
intrinsically
involved,
and this
strongly
motivates,
as
we shall discuiss
further
in
Section IV
below, control over
prices
and
benefits.
The
simplest
administrative
form is
the
closed
panel;
physi-
cians
involved
are,
in
effect,
the
insuring agent.
From this
point
of
view,
Blue Cross solved
the
prepayment
problem
by
universalizing
the
closed
panel.
The
case that
price
discrimination
by
income is
a form
of
profit
maximization
which
was
zealously
defended by
opposition
to fees
for
service seems
far
from
proven.
But
it
remains
true
that this
price
dis-
crimination,
for
whatever
cause,
is
a
source of
nonoptimality.
Hypo-
thetically,
it
means
everyone
would
be
better off
if
prices
were
made
equal
for
all,
and
the
rich
compensated
the
poor
for
the
changes in
the
relative
positions.
The
importance
of
this
welfare loss
depends on
the
actual
amount of discrimination
and on
the
elasticities of
demand
for
medical
services
by
the
different
income
groups.
If
the
discussion is
simplified
by
considering
only
two
income
levels,
rich
and
poor,
and if
the
elasticity
of
demand
by
either
one is
zero,
then
no
reallocation of
medical services
will
take
place
and
the initial
situation
is
optimal.
The
958
THE
AMERICAN ECONOMIC
REVIEW
only
effect of a change in
price will be the
redistribution of income
as
between
the
medical
profession and the group with
the
zero
elasticity
of
demand. With low
elasticities of demand, the
gain will be small.
To
illustrate, suppose the price
of medical care to the
rich is double that to
the
poor,
the
medical
expenditures by the
rich
are
20 per cent of those
by
the
poor,
and
the
elasticity
of demand for
both
classes is
.5; then
the
net
social
gain due to the
abolition of
discrimination is slightly over
1 per
cent of previous
medical expenditures.33
The
issues involved in the
opposition to
prepayment, the other major
anomaly
in
medical pricing,
are not meaningful
in the world of cer-
tainty
and will be discussed
below.
IV.
Comparison with the
Ideal Competitive
Model under Uncertainty
A.
Introduction
In
this section
we will
compare the operations
of the actual medical-
care market
with those
of
an
ideal system in
which not only the usual
commodities and services
but also insurance
policies against all con-
ceivable
risks
are
available.3
Departures consist
for the most part of
3It is assumed
that
there are
two classes,
rich and poor;
the price
of medical
services
to the
rich is twice
that to the
poor, medical
expenditures by
the rich are
20 per
cent
of
those
by the poor,
and the
elasticity of
demand for
medical services is
.5 for
both
classes.
Let
us
choose
our quantity
and
monetary units so
that the
quantity of
medical
services
consumed by
the poor
and
the price
they pay are
both 1. Then
the rich
pur-
chase .1
units
of
medical services
at a price
of 2. Given
the
assumption about
the
elasticities
of
demand,
the demand
function of the rich
is
DR(p)
-
.14
p--5
and
that
of
the poor is
Dp(p)
=
p`.
The
supply
of
miiedical services
is
assumed
fixed and
therefore
must
equal 1.1. If
price
discrimination were
abolished, the
equilibrium
price, p,
must
satisfy
the relation,
DR(P)
+
Dp(p)
1.1,
and therefore
p
=
1.07. The
quantities of medical
care
purchased by the rich
and
poor,
respectively, would
beDR(7p)
=
.135
and
Dp(75)
=
.965.
The
inverse demand
functions, the
priCe to be
paid
corresponding to any
given quantity
are
djv(q)
= .02/q2,
and
dp(q)
=
l/q'. Therefore, the
consumers' surplus
to the rich
generated by the
change is:
r
135
(1)
J
(.02/q2)dq
-
7(.135
-
.1),
and
similarly
the
loss
in consumers'
surplus by the
poor is:
(2)
f
(l/q2)dq
-
p(1
-
.965)
.965
If
(2)
is subtracted
from (1), the
second
terms cancel, and
the aggregate
increase in
consumers'
surplus is
.0156, or a
little over 1
per cent of
the initial
expenditures.
'A
striking
illustration of the
desire for
security in
medical care
is
provided
by the
expressed
preferences
of
etmigr&s
from the Soviet
Union as between
Soviet
medical
prac-
tice
and German
or
American
practice; see Field
[14, Ch.
12].
Those in
Germany pre-
ferred
the
German
system to the
Soviet, but
those in the
United States preferred
(in
a
ratio of
3 to 1) the
Soviet
system. The
reasons given boil
down to the
certainty
of
medical
care,
independent of
income or health
fluctuations.
ARROW:
UNCERTAINTY
AND
MEDICAL
CARE
959
insurance
policies
that
might
conceivably
be
written, but are
in
fact
not.
Whether
these
potential
commodities
are
nonmarketable,
or,
merely
because
of
some
imperfection
in the
market,
are
not
actually
marketed,
is a
somewhat
fine
point.
To recall
what has
already
been
said
in
Section
I,
there are
two
kinds
of
risks
involved in
medical
care: the risk
of
becoming
ill,
and
the
risk
of
total
or
incomplete
or
delayed
recovery.
The loss
due to
illness
is
only
partially
the
cost
of medical
care.
It
also consists
of
dis-
comfort
and
loss of
productive
time
during
illness,
and,
in
mole
serious
cases,
death
or
prolonged
deprivation
of normal function.
From
the
point
of
view
of
the
welfare economics of
uncertainty,
both
losses
are
risks
against
which
individuals
would
like
to
insure.
The nonexistence
of
suitable
insurance
policies for
either
risk
implies
a loss of
welfare.
B.
The
Theory
of
Ideal
Insuran cc
In
this
section,
the
basic
principles of
an
optimal
regime
for risk-
bearing
will
be
presented.
For
illustration,
reference will
usually
be
made to
the case
of
insurance
against
cost
in
medical
care. The
princi-
ples
are
equally
applicable
to
any
of
the
risks.
There is
no
single
source to
which
the
reader
can
be
easily
referred,
though
I
think the
principles are
at
least
reasonably
well
understood.
As a
basis
for
the
analysis, the
assumption
is
made
that
each
individ-
ual
acts
so
as
to
maximize
the
expected
value
of a
utility
function.
If
we
think of
utility
as
attached
to
income,
then the
costs of medical
care
act as a
random
deduction
from
this
income,
and it
is
the
expected
value
of
the
utility
of
income
after medical
costs
that
we
are
concerned
with. (Income after
mnedical
costs is
the
ability
to
spend
money
on
other
objects
which
give
satisfaction.
We
presuppose
that
illness
is
not
a
source of
satisfaction
in
itself;
to
the
extent
that it is
a
source
of
dissatisfaction,
the illness
should
enter
into
the
utility function
as
a
separate
variable.) The
expected-utility
hypothesis,
due
originally
to
Daniel
Bernoulli
(1738),
is
plausible
and is
the
most
analytically
man-
ageable
of all
hypotheses that
have
been
proposed
to
explain
behavior
under
uncertainty.
In
any
case,
the
results
to
follow
probably
would
not
be
significantly
affected
by
moving
to
another
mode
of
analysis.
It is
further
assumed
that
individuals are
normally
risk-averters.
In
utility
terms,
this
means
that
they
have
a
diminishing
marginal
utility
of
income. This
assumption
may
reasonably
be
taken to
hold for
most
of the
sKgnificant
affairs of
life for
a
majority
of
people,
but
the
pres-
ence
of
gamibling
provides some
difficulty in
the
full
application
of
this
view. It
follows
from
the
assumption
of
risk
aversion
that
if an
indi-
vidual
is
given a
choice
between
a
probability
distribution
of
income,
with
a
given
mean
n,
and the
certainty of the
income
m,
he
would
prefer
960
THE AMERICAN
ECONOMIC
REVIEW
the
latter.
Suppose, therefore,
an
agency,
a
large
insurance
company
plan, or
the
government, stands
ready to
offer insurance
against medical
costs on
an
actuarially
fair
basis;
that
is,
if
the costs
of medical
care
are a
random
variable with
mean
n, the
company will
charge
a
pre-
mium
n,
and
agree to
indemnify the individual for all medical costs.
Under these
circumstances,
the
individual
will
certainly prefer
to take
out
a
policy and
will
have a
welfare
gain
thereby.
Will
this be a social
gain?
Obviously
yes,
if
the
insurance
agent
is
suffering
no social
loss. Under
the
assuimption
that medical
risks
on
different individuals are
basically
independent, the
pooling
of them
reduces the risk
involved
to
the insurer
to
relatively
small proportions.
In
the
limit,
the welfare
loss, even
assuming risk
aversion on the
part
of the
insurer,
would
vanish
and
there
is a
net social gain
which
may
be
of
quite substantial
magnitude.
In
fact,
of
course, the
pooling of
risks
does not
go
to
the
limit;
there
is
only
a
finite number
of them
and
there
may
be
some
interdependence
among
the
risks due
to epidemics
and the
like.
But
then a
premium, perhaps
slightly
above the actuarial
level,
would
be sufficient to
offset
this welfare
loss.
From the
point
of
view
of
the
individual, since
he
has a
strict
preference for the
actuari-
ally
fair
policy
over
assuming the risks
himself, he
will still
have
a
preference
for an
actuarially
unfair
policy, provided,
of course, that
it is not too
unfair.
In addition to
a
residual
degree
of
risk
aversion
by insurers,
there
are other
reasons
for
the
loading of the
premium
(i.e., an
excess
of
premium
over
the
actuarial
value). Insurance
involves
administrative
costs. Also, because of the
irregularity
of
payments there
is likely
to
be
a cost
of
capital
tied
up.
Suppose,
to
take a
simple
case, the insurance
company
is not
willing
to sell
any insurance
policy
that a consumer
wants but
will
charge
a
fixed-percentage
loading
above the
actuarial
value for its
premium.
Then it
can
be
shown
that the most
preferred
policy
from the
point
of
view of
an
individual
is a
coverage
with a
deductible
amount;
that
is,
the
insurance
policy
provides 100 per
cent
coverage
for all
medical costs in
excess
of
some
fixed-dollar
limit. If,
however,
the
insurance
company
has
some
degree of
risk
aversion, its
loading may
also
depend
on
the
degree
of
uncertainty of the
risk. In
that
case,
the Pareto
optimal
policy
will
involve some
element
of co-
insurance, i.e.,
the
coverage
for
costs over
the
minimum limit
will be
some
fraction less than 100
per
cent
(for
proofs
of
these
statements,
see
Appendix).
These results
can
also be
applied
to the
hypothetical
concept
of in-
surance
against
failure to
recover from
illness.
For
simplicity,
let us
assume
that the
cost
of failure to recover
is
regarded
purely as a
money
cost,
either
simply productive
opportunities
foregone
or, more
gener-
ARROW:
UNCERTAINTY
AND
MEDICAL
CARE
961
ally,
the
money
equivalent of
all
dissatisfactions.
Suppose further
that,
given
that
a
person
is
ill, the
expected
value
of
medical
care
is
greater
than its
cost;
that
is,
the
expected
money
value
attributable
to
recovery
with
medical
help is
greater
than
resources
devoted
to
medi-
cal
help.
However,
the
recovery,
though
on
the
average
beneficial,
is
uncertain;
in
the
absence
of
insurance a
risk-averter
may well
prefer
not
to
take a
chance on
further
impoverishment
by
buying
medical
care.
A
suitable
insurance
policy
would,
however, mean that
he paid
nothing if
he
doesn't
benefit;
since
the
expected
value is
greater
than
the
cost, there
would be
a
net
social
gain.35
C. Problems
of
Insurance
1. The
moral
hazard.
The
welfare
case for
insurance
policies
of
all
sorts
is
overwhelming. It
follows
that
the
government should
under-
take
insurance
in
those
cases
where
this
market, for
whatever
reason,
has
failed
to
emerge.
Nevertheless,
there
are
a
number
of
significant
practical
limitations
on
the use
of
insurance.
It is
important to
under-
stand
them,
though
I do
not
believe
that
they
alter the
case
for the
creation
of
a
much
wider
class of
insurance
policies
than
now exists.
One
of
the
limits
which
has been much
stressed in
insurance litera-
ture is
the
effect of
insurance
on
incentives.
What is
desired in the
case
of
insurance is
that
the
event
against
which
insurance is
taken
be out
of
the control
of
the
individual.
Unfortunately,
in real life
this
separa-
tion can never
be
made
perfectly.
The outbreak
of
fire in
one's
house
or
business
may be
largely
uncontrollable by
the
individual,
but
the
probability
of
fire is
somewhat
influenced
by
carelessness,
and of course
arson is
a
possibility,
if
an
extreme
one.
Similarly, in
medical
policies
the
cost
of
medical
care
is
not
completely
determined
by
the illness
suffered
by the
individual
but
depends
on the
choice of
a
doctor
and
his
willingness
to
use
medical
services.
It is
frequently
observed
that
widespread medical
insurance
increases the
demand
for
medical
care.
Coinsurance
provisions
have
been
introduced
into
many
major
medical
policies
to
meet this
contingency
as
well as the
risk
aversion
of the
in-
surance
companies.
To
some extent
the
professional
relationship between
physician
and
patient limits the normal
hazard in
various
forms of
medical
insurance.
By
certifying
to
the
necessity
of
given
treatment
or the
lack
thereof,
the
physician
acts as
a
controlling
agent on
behalf of
the
insurance
companies. Needless
to
say,
it is
a
far
from
perfect
check;
the
phy-
sicians
themselves
are
not
under
any
control
and
it
may
be
convenient
for them
or
pleasing
to
their
patients
to
prescribe
more
expensive
medi-
"It
is a
popular
belief
that
the
Chinese,
at one
time,
paid
their
physicians
when
well
but not
when
sick.
962
THE
AMERICAN ECONOMIC
REVIEW
cation,
private
nurses,
more
frequent
treatments,
and
other
marginal
variations of
care. It
is
probably true that
hospitalization
and
surgery
are
more
under
the
casual
inspection of
others than is
general
practice
and
therefore less
subject to
moral
hazard;
this
may
be
one
reason
why
insurance
policies
in
those
fields
have
been more
widespread.
2. Alternative
methods
of
insurance
payment.
It is
interesting
that
no
less
than
three
different
methods of
coverage
of
the
costs
of
medical
care
have
arisen:
prepayment,
indemnities
according
to a fixed
schedule,
and
insurance
against
costs,
whatever
they
may
be.
In
prepayment
plans,
insurance
in
effect
is
paid
in
kind-that
is,
directly
in medical
services.
The
other
two
forms
both
involve
cash
payments
to the bene-
ficiary, but
in
the
one
case
the
amounts
to be
paid
involving
a
medical
contingency are
fixed
in
advance,
while in
the other the
insurance
car-
rier
pays all
the
costs,
whatever
they
may
be,
subject,
of
course,
to
provisions
like
deductibles
and
coinsurance.
In
hypothetically
perfect
markets
these
three forms of
insurance
would be
equivalent.
The
indemnities
stipulated
would,
in
fact, equal
the
market
price
of
the
services,
so
that
value
to the insured
would
be
the same if
he
were to be
paid
the fixed sum or
the market
price
or
were
given
the
services
free.
In
fact,
of
course,
insurance
against
full
costs and
prepayment
plans
both
offer
insurance
against
uncertainty
as
to the
price of
medical
services, in
addition
to
uncertainty
about their
needs.
Further,
by
their
mode of
compensation
to
the
physician,
pre-
payment
plans
are
inevitably
bound up
with
closed
panels so
that
the
freedom of
choice of
the
physician
by
the
patient is
less
than
it
would
be
under a
scheme
more
strictly confined
to the
provision of
insurance.
These
remarks
are
tentative,
and
the
question
of
coexistence of
the
different
schemes
should
be a
fruitful
subject
for
investigation.
3.
Third-party control over
payments.
The
moral
hazard
in
phy-
sicians' control
noted in
paragraph 1
above
shows
itself
in
those
in-
surance schemes where
the
physician
has the
greatest
control,
namely,
major
medical
insurance.
Here
there
has
been
a
marked
rise in
ex-
penditures
over
time.
In
prepayment
plans,
where
the
insurance
and
medical service
are
supplied
by
the
same
group,
the
incentive
to
keep
medical
costs to a
minimum is
strongest.
In
plans
of the
Blue
Cross
group,
there
has
developed a
conflict of
interest
between
the
insurance
carrier
and
the
medical-service
supplier,
in
this
case
particularly
the
hospital.
The
need for
third-party control
is
reinforced
by
another
aspect
of
the
moral
hazard. Insurance
removes
the
incentive
on
the
part of
in-
dividuals,
patients,
and
physicians
to
shop
around for
better
prices
for
hospitalization and
surgical
care.
The
market
forces,
therefore,
tend to
be
replaced
by
direct
institutional
control.
ARROW:
UNCERTAINTY
AND
MEDICAL CARE
963
4.
Administrative
costs. The
pure theory
of insurance
sketched
in
Section B
above omits
one very
important
consideration:
the costs
of
operating an
insurance company.
There are
several types
of
operating
costs, but
one of the
most
important
categories includes
commissions
and
acquisition costs,
selling costs
in usual
economic
terminology.
Not
only does
this mean
that
insurance policies
must be sold
for consid-
erably more
than
their actuarial
value, but
it also means
there
is
a
great
differential
among different
types of
insurance. It is
very striking
to
observe that among
health
insurance
policies of insurance
companies
in
1958,
expenses of
one sort or
another
constitute 51.6 per
cent of total
premium
income for
individual
policies, and
only 9.5 per
cent for group
policies
[26, Table
14-1, p.
272].
This
striking differential
would seem
to
imply
enormous
economies of
scale in the
provision of
insurance, quite
apart
from the
coverage of the
risks
themselves.
Obviously, this pro-
vides a
very strong
argument for
widespread
plans,
including, in par-
ticular,
compulsory
ones.
5.
Predictability
and insurance.
Clearly,
from the
risk-aversion point
of
view,
insurance is
more
valuable, the
greater the
uncertainty in the
risk
being insured
against. This
is usually
used as an
argument for
putting
greater
emphasis on
insurance against
hospitalization and sur-
gery
than
other
forms of medical
care. The
empirical
assumption has
been
challenged by 0.
W.
Anderson and
others [3, pp.
53-54],
who as-
serted
that
out-of-hospital
expenses were
equally as
unpredictable
as
in-hospital
costs.
What was in
fact shown
was that the
probability of
costs
exceeding $200
is about the
same for
the two
categories, but this
is
not, of
course, a
correct
measure of
predictability, and a
quick glance
at the
supporting
evidence shows
that in
relation to the
average cost
the
variability
is much lower
for
ordinary
medical
expenses. Thus,
for
the
city
of
Birmingham,
the mean
expenditure
on
surgery
was
$7,
as
opposed
to $20
for
other
medical expenses,
but of
those who paid
something
for
surgery
the average bill
was
$99,
as against
$36
for
those
with
some ordinary
medical
cost.
Eighty-two
per cent of
those inter-
viewed had no
surgery,
and
only 20
per cent
had no
ordinary medical
expenses
[3,
Tables
A-13, A-18, and
A-19 on
pp. 72, 77, and
79,
re-
spectively].
The issue of
predictability
also has
bearing
on
the merits of insur-
ance
against chronic illness
or
maternity.
On a lifetime
insurance
basis,
insurance
against chronic
illness makes
sense,
since
this
is
both
highly
unpredictable
and
highly significant
in
costs.
Among
people
who
al-
ready
have chronic
illness,
or
symptoms
which
reliably
indicate
it,
in-
surance
in
the
strict
sense
is
probably pointless.
6.
Pooling of unequal
risks.
Hypothetically,
insurance
requires
for
its
full
social
benefit
a
maximum
possible
discrimination
of
risks. Those
964
THE
AMERICAN
ECONOMIC
REVIEW
in
groups
of higher
incidences of
illness
should pay
higher premiums.
In fact,
however,
there is a
tendency
to
equalize,
rather than to
differ-
entiate,
premniums,
especially in the
Blue
Cross and similar
widespread
schemes. This
constitutes,
in
effect,
a
redistribution
of income
from
those with a
low
propensity
to
illness to
those with
a
high
propensity.
The
equalization,
of course,
could
not
in
fact
be
carried
through
if
the
market were
genuinely
competitive.
Under
those
circumsances,
insur-
ance
plans
could
arise which
charged lower
premiums
to
preferred
risks and
draw
them off,
leaving the
plan
which does
not discriminate
among
risks
with
only an
adverse
selection of
them.
As we
have
already seen
in the
case of
income
redistribution, some
of this
may be
thought of
as
insurance with
a longer
time
perspeCtive.
If
a
plan
guarantees to
everybody a
premium
that
corresponds
to
total
experience but
not
to
experience as
it might
be
segregated by smaller
subgroups,
everybody is, in
effect,
insured
against a
change
in
his
basic
state
of
health which
would
lead to a
reclassification.
This
corresponds
precisely
to the
use of a
level
premium in
life
insurance
instead of a
premium
varying
by age,
as would
be the
case for
term
insurance.
7.
Gaps
and
coverage.
We
may
briefly
note
that,
at
any
rate
to
date,
insurances
against
the cost
of
medical
care
are
far from
universal.
Cer-
tain
groups-the
unemployed,
the
institutionalized,
and
the
aged-are
almost
completely
uncovered. Of
total
expenditures,
between
one-fifth
and
one-fourth are
covered
by
insurance. It
should be
noted,
however,
that
over
half of
all
hospital
expenses
and
about
35
per
cent
of
the
medical
payments
of
those
with
bills
of
$1,000
a
year
and
over,
are
in-
cluded
[26, p.
376]. Thus,
the
coverage
on the
more
variable
parts
of
medical
expenditure is
somewhat
better than
the
over-all
figures would
indicate,
but it
must be
assumed
that the
insurance
mechanism is still
very
far from
achieving
the full
coverage
of
which
it is
capable.
D.
Uncertainty of
Effects
of
Treatment
1. There are
really
two
major
aspects
of
uncertainty for
an indi-
vidual
already
suffering
from
an
illness. He is
uncertain about the
effec-
tiveness
of medical
treatment,
and
his
uncertainty
may be
quite differ-
ent from
that
of
his
physician, based oni the
presumably quite
different
medical
knowledges.
2.
Ideal
insurance. This
will
necessarily involve
insurance
against
a failure to
benefit from
medical
care,
whether
through
recovery, relief
of
pain,
or
arrest of
further
deterioration.
One
form
would be
a system
in
which the
payment
to the
physician
is
made in
accordance
with the
degree
of benefit.
Since
this
would
involve
transferring the
risks from
the
patient
to
the
physician,
who
might
certainly
have an
aversion to
bearing
them,
there is room for
insurance
carriers to
pool
the risks,
ARROW:
UNCERTAINTY
AND
MEDICAL
CARE
965
either by
contract
with
physicians or by
contract with
the potential
patients.
Under ideal
insurance,
medical care
will always
be undertaken
in any
case
in
which
the
expected utility,
taking account of the
prob-
abilities,
exceeds the
expected
medical cost.
This
prescription
would
lead to
an economic
optimum.
If we think
of the
failure to
recover
mainly
in
terms of
lost working
time, then
this
policy
would,
in
fact,
maxi-mize
economic
welfare as
ordinarily
measured.
3. The
concepts of
trust and
delegation. In
the absence
of
ideal
in-
surance,
there
arise
institutions
which
offer some
sort
of
substitute
guarantees. Under ideal
insurance the
patient
would
actually
have
no
concern
with
the
informational
inequality
between
himself and
the
physician, since he
would only
be paying by
results
anyway,
and his
utility position
would
in
fact be
thoroughly
guaranteed.
In
its absence
he
waants
to
have
some guarantee
that
at least the
physician
is
using
his
knowledge to
the best
advantage.
This
leads to the
setting up
of a
relationship
of
trust
and
confidence, one
which
the
physician
has
a
social
obligation to
live up to.
Since the
patient does not,
at least
in
his
belief,
know
as much as
the
physician, he
cannot
completely
enforce
standards
of
care.
In
part,
he
replaces
direct
observation by
gener-
alized belief
in
the
ability
of
the
physician." To
put it
another
way, the
social
obligation for
best
practice is part of
the
commodity the
phy-
sician
sells,
even
though it is a
part that is
not subject to
thorough
in-
spection
by the
buyer.
One
consequence
of
such
trust relations is
that
the
physician cannot
act,
or
at
least appear
to act, as if
he is
maximizing his
income at
every
moment
of
time.
As
a
signal to
the
buyer of
his
intentions
to act as
thorouglhly
in
the
buyer's
behalf as
possible,
the physician avoids the
obvious
stigmata
of
profit-maximizing.
Purely arms-length
bargaining
behavior would be
incompatible, not
logically, but
surely psychologi-
cally,
with
the
trust
relations.
From
these
special relations come
the
various forms
of
ethical behavior discussed
above,
and so
also,
I
sug-
gest,
the
relative
un-importance
of
profit-making
in
hospitals.
The
very
word,
"profit,"
is a
signal
that denies
the
trust
relations.
PriCe
discrimination
and its
extreme, free
treatment for
the
indigent,
also
follow. If the
obligation of the
physician
is understood
to be
first
of
all to
the
welfare
of
the
patient, then
in
particular it
takes
preced-
ence
over
financial
difficulties.
As
a second
consequence
of
informational
inequality between
phy-
siclan and
patient
and
the lack of
insurance of
a
suitable type,
the
patient
must
delegate
to the
physician
much
of
his
freedom of
choice.
"
Francis
Bator
points
out
to
me
that
some protection
can be
achieved, at a
price,
by
securing
additional
opinions.
966
THE
AMERICAN
ECONOMIC
REVIEW
He
does
not
have
the
knowledge
to
make
decisions
on
treatment,
re-
ferral, or
hospitalization. To
justify
this
delegation,
the
physician finds
himself
somewhat
limited,
just
as any
agent
would
in
similar
circum-
stances.
The
safest
course
to
take to
avoid
not
being
a
true
agent
is
to
give the
socially
prescribed
"best"
treatment of
the
day.
Compromise
in
quality,
even
for the
purpose
of
saving
the
patient
money, is
to
risk
an
imputation
of
failure
to
live up
to
the
social
bond.
The
special
trust
relation
of
physicians
(and
allied
occuptions,
such
as
priests)
extends to
third
parties
so
that the
certifications
of
phy-
sicians
as to
illness
and
injury
are
accepted as
especially
reliable
(see
Section
IJ.B
above).
The
social
value
to
all concerned
of such
pre-
sumptively
reliable
sources
of
information is
obvious.
Notice the
general
principle here.
Because there are
barriers
to
the
information
flow
and
because
there
is no
market
in
which
the
risks
involved
can
be
insured,
coordination
of
purchase
and
sales
must talke
place
through
convergent
expectations,
but
these
are
greatly
assisted
by
having clear
and
prominent
signals, and
these,
in
turn,
force
pat-
terns of
behavior
which
are not
in
themselves
logical
necessities
for
optimality.37
4.
Licensing
and
educational
standards.
Delegation
and
trust
are
the
social
institutions
designed
to
obviate the
problem of
informational
in-
equality.
The
general
uncertainty
about tne
prospects of medical
treat-
ment is
socially
handled
by
rigid
entry
requirements.
These
are de-
signed
to reduce
the
uncertainty
in
the
mind of the consumer
as
to
the
quality
of
product
insofar
as
this
is
possible.38
I
think
this
explana-
tion,
which
is
perhaps
the
naive
one,
is
much
more
tenable
than
any
idea of
a
monopoly
seeking
to
increase
incomes. No
doubt
restriction
on
entry is
desirable
from
the
point
of
view of
the
existing
physicians,
but
the
public
pressure
needed
to
achieve
the
restriction
must
come
from
deeper
causes.
The
social
demand
for
guaranteed
quality
can be
met
in
more
than
one
way,
however.
At
least
three
attitudes
can
be
taken
by the
state
or
other
social
institutions
toward
entry into
an
occupation
or
toward
the
production
of
commodities in
general;
examples of
all
three
types
exist.
(1)
The
occupation can
be
licensed,
nonqualified
entrants
being
simply
excluded. The
licensing
may
be
more
complex
than
it is in
medicine;
individuals
could be
licensed for
some,
but not
all,
medical
activities,
for
example.
Indeed, the
present
all-or-none
approach
could
"The
situation
is
very
reminiscent
of
the
crucial
role of
the
focal
point in
Schelling's
theory of tacit
games,
in
which
two
parties
have
to
fin-d
a
common
course
of
action
without
being
able to
communicate;
see
[24,
esp.
pp.
225
ff.].
'
How
well
they
achieve
this end
is
another
matter.
R. Kessel
points
out to me
that
they
merely
guarantee
training,
not
continued
good
performance
as
medical
technology
changes.
ARROW:
UNCERTAINTY
AND MEDICAL
CARE
967
be
criticized as
being
insufficient with
regard
to
complicated
specialist
treatment,
as well as
excessive with
regard
to
minor
medical
skills.
Graded
licensing
may,
however,
be
much
harder
to
enforce.
Controls
could
be
exercised
analogous to
those for
foods;
they
can be
excluded
as
being
dangerous,
or
they
can be
permitted
for
animals
but
not
for
humans.
(2)
The
state
or
other
agrency
can
certify
or
label,
without
compulsory
exclusion.
The
category
of
Certified
Psychologist
is
now
under
active
discussion;
canned
goods
are
graded.
Certification
can
be
done
by
nongovernmental
agencies,
as in the medical-board
examina-
tions for
specialists.
(3)
Nothing
at all
may be done; consumers
make
their
own
choices.
The
choice
among
these
alternatives
in
any
given
case
depends
on
the
degree
of
difficulty consumers
have in
making
the choice
unaided,
and
on
the
consequences
of
errors of
judgment. It
its the
general
social
con-
sensus,
clearly,
that
the
laisscz-faire
solution
for
medicine
is
intolerable.
The
certification
proposal
never
seems
to
have
been
discussed
seriously.
It is
beyond
the
scope of
this
paper
to
discuss
these
proposals
in
detail.
I
wish
simply
to
point
out
that
they
should
be
judged
in
terms of
the
ability to
relieve
the
uncertainty of
the
patient in
regard
to
the
quality
of
the
commodkty he
is
purchasing,
and
that
entry
restrictions
are
the
consequences
of
an
apparent
inability
to
devise
a
system
in
which
the
risks
of
gaps
in
medical
knowledge
and
skill
are
borne
primarily
by
the
patient,
not
the
physician.
Postscript
I
wish
to
repeat
here
what
has
been
suggested
above
in
several
places:
that
the
failure
of
the
market
to
insure
against
uncertainties
has
created
many
social
institutions in
which
the
usual
assumptions
of
the
market
are to
some
extent
contradicted.
The
medical
profession
is
only
one
example,
though
in
many
respects
an
extreme
one.
All
pro-
fessions
share
some
of
the
same
properties.
The
eConomic
importance
of
personal
and
especially
family
relationships, though
declining,
is
by
no
means
trivial
in
the
most
advanced
economies;
it is
based
on
non-
market
relations
that
create
guarantees
of
behavior
which
would
other-
wise be
afflicted
with
excessive
uncertainty.
Many
other
examples
can
be
given.
The
logic
and
limitations
of
ideal
competitive
behavior
under
uncertainty
force
us
to
recognize
the
incomplete
description of
reality
supplied
by
the
impersonal
price
system.
REFERENCES
1.
A.
A.
ALCEIAN,
K.
J.
ARROW, AND
WV.
M.
CAPRON,
An
Economic
Analysis
of
the
Market
for
Scientists
and
Engineers,
RAND
RM-2190-RC.
Santa
Monica
1958.
968
THE
AMERICAN
ECONOMIC
REVIEW
2. M.
ALLAIS,
"Ge'neralisation des theories de
l'6quilibre
economique
general
et
du rendement
social au cas du
risque,"
in
Centre National de
la
Recherche Scientifique,
Econometrie, Paris
1953, pp.
1-20.
3. 0.
WV.
ANDERSON AND
STAFF OF THE NATIONAL
OPINION
RESEARCH
CENTER, Voluntary
Health
Insurance
in Two
Cities. Cambridge,
Mass.
1957.
4.
K. J.
ARROW, "EIconomic
Welfare and the
Allocation of Resources
for
Invention," in Nat. Bur.
Econ. Research,
The Role and Direction
of
Inventive Activity:
Economic and Social
Factors, Princeton 1962,
pp.
609-2
5.
5.
, "Les
role
des
valeurs
boursieres
pour
la
repartition
la
meilleure
des
risques,"
in
Centre National
de la
Recherche Scientifique,
Econo-
mietrie, Paris
1953,
pp.
41-46.
6.
F.
M. BATOR, "The
Anatomy of Market
Failure," Quart. Jour.
Econ.
Aug.
1958, 72, 351-79.
7. E.
BAUDIER,
"L'introduction du temps dans la
theorie
de
l'equilibre gen-
eral,"
Les Cahziers
Economiques, Dec. 1959,
9-16.
8.
W. J.
BAUMOL, Welfare
Economics azd the
Theory of the State.
Cam-
bridge,
MIass. 1952.
9. K.
BORCT-I, "The Safety
Loading of
Reinsurance Premiums,"
Skandi-
navisk
Aktuariehdskrift,
1960,
pp.
163-84.
10.
J.
M. BUCHANAN AND
G.
TULLOCK, The Calculus
of
Consent.
Ann
Arbor 1962.
11.
G.
DEBREU, "Une
economique de
l'incertain," Economie Appliqutee
1960,
13,
111-16.
12.
--, Theory of Values.
New York 1959.
13.
R.
DUBOS,
"Medical
Utopias,"
Daedalus, 1959,
88,
410-24.
14.
M. G.
FIELD,
Doctor and
Patient
in
Soviet Russia.
Cambridge,
Mass.
1957.
15. MILTON
FRIEDMAN,
"The Methodology of
Positive
Economics,"
in
Essays in Positive
Economics, Chicago 1953,
pp.
3-43.
16. AND
S. S.
KuZNETS, Income from
Independent Professional
Practice.
Nat. Bur.
Econ.
Research,
New York
1945.
17.
R.
A.
KESSEL,
"Price Discrimination in
Medicine,"
Jour.
Law
and
Econ..,
1958,
1,
20-53.
18. T. C. KOOPMANS,
"Allocation
of Resources
and the
Price
System,"
in
Three
Essays on the
State of Economic Science, New York 1957,
pp.
1-120.
19. I. M.
D.
LITTLE, A Critique
of Welfare
Economics.
Oxford 1950.
20.
SELMA
MUSHKIN,
"Towards a Definition of
Health Economics,"
Public
Health
Reports, 1958, 73,
785-93.
21. R.
R.
NELSON, "The
Simple Economics of
Basic Scientific
Research,"
Jour.
Pol.
Econt., June
1959, 67,
297-306.
22. T.
PARSONS, The Social
System. Glencoe 1951.
23. M. J. PECK AND
F. M.
SCHERER, The
TVeaponzs Acquisition
Process:
An
Economic Analysis. Div.
of
Research,
Graduate School
of
Business,
Harvard University,
Boston 1962.
ARROW: UNCERTAINTY AND MEDICAL CARE 969
24. T. C. SCHELLING,
T
he Strategy of
Conflict.
Cambridge, Mass. 1960.
25. A. K. SHAPIRO, "A Contribution to a History of the Placebo Effect,"
Behavioral Science,
1960,
5, 109-35.
26. H. M. SOMERS AND A. R. SOMERS, Doctors, Patients, and IHealth In-
surance. The Brookings Institution, Washington 1961.
27. C. L. STEVENSON, Ethics and Lan-guage. New Haven 1945.
28. U. S. DEPARTMENT OF HEALTH, EDUCATION AND WELFARE, Physicians
for a
GrowZOing
Amterica,
Public Health Service Publication No. 709, Oct.
1959.
APPENDIX
On
Optimal
Insurance Policies
The
two
propositions
about the
nature of
optimal insurance
policies
as-
serted in
Section
IV.B
above will be
proved
here.
Proposition 1. If
an
insurance
company is
willing
to offer
any
insurance
policy against
loss
desired
by the
buyer
at a
premium
which
depends
only
on
the
policy's
actuarial
value,
then the
policy chosen
by
a
risk-averting
buyer will
take
the form of
100 per
cent
coverage above
a deductible
mini-
mum.
Note:
The
premium
will,
in
general, exceed
the actuarial
value;
it
is
only required
that
two
policies with
the same actuarial
value
will
be
offered
by
the
company
for the
same
premium.
Proof:
Let W
be the
initial wealth
of the
individual,
X
his
loss,
a
random
variable,
I(X) the
amount
of insurance
paid
if
loss
X
occurs,
P
the
pre-
mium,
and Y(X)
the
wealth of the
individual after
paying
the
premium,
incurring
the loss,
and
receiving the
insurance benefit.
(1)
Y(X) =W-P-X
+
I(X).
The
individual
values
alternative
policies
by the
expected
utility
of his
final
wealth
position,
Y(X). Let
U(y) be the
utility of
final
wealth, y; then
his
aim is
to
maximize,
(2)
Et
U[Y(X)]},
where
the
symbol,
E,
denotes
mathematical
expectation.
An
insurance
payment is
necessarily
nonnegative,
so the insurance
policy
must
satisfy the
condition,
(3)
I(X)
>
0
for
all X.
If
a
policy is
optimal, it
must in
particular be
better in the
sense of
the
criterion
(2), than
any
other
policy with
the same
actuarial
expectation,
E[I(X)I.
Consider
a policy
that
pays some
positive
amount of
insurance at
one
level
of loss,
say
X,,
but which
permits
the final
wealth at
some
other
loss level,
say X2,
to be
lower than
that
corresponding to
X,.
Then,
it is
intuitively
obvious that a
risk-averter
would prefer
an
alternative
policy
with the
same
actuarial
value which
would
offer
slightly less
protection
for
losses
in
the
neighborhood
of
X,
and slightly
higher
protection
for
those in
the
neighborhood
of
X2, since risk
aversion
implies
that the
marginal
utility
970 THE
AMERICAN ECONOMIC REVIEW
of
Y(X)
is
greater
when
Y(X)
is
smaller: hence, the original policy cannot be
optimal.
To
prove
this
formally,
let
11(X)
be the original policy, with 11(X) >0 and
Yl(Xl)
> Y2(X2),
where
Y1(X) is
defined in terms of 11(X) by (I). Choose
a
sufficiently small so that,
(4) 11(X) >
0
for
X1
<
X
<
X1
+
3,
(5) Y1(X') <
Y1(X)
for X2
<
X'
<
X2 +
3a
X1
<
X
<
X1 +
&.
(This choice of a
is
possible
if
the
functions 11(X), Y1(X) are continuous;
this can be
proved
to be true
for the
optimal policy, and therefore we need
only
consider
this
case.)
Let 7r- be the probability
that the loss, X, lies
in
the interval (X1,
X1+6),
72
the
probability that
X
lies
in
the interval (X2,
X2+3).
From (4)
and
(5) we can choose E>0 and
sufficiently small so that,
(6) I1(X) -72E
>
0
for
Xi
<
X
<
X1
+
a,
(7) Y1(X') +
7riE
< Y1(X)
-
7r2E
for
X2<
X'
<
X2+
3,
X1
<
X
<
X1 +
S.
Now define a
new
insurance
policy, 12(X),
which
is the
same
as
11(X) except
that
it
is
smaller
by 72E
in
the
interval from
X1
to X1+8 and larger by
7r,,E
in the
interval from
X2
to X2+8.
From (6), 12(X)
>0
everywhere, so that
(3)
is
satisfied. We will show that
E[11(X)]
=
E[I2(X)]
and that
I2(X)
yields
the
higher expected utility,
so that
I1(X)
is
not optimal.
Note that
I2(X)
-
1(X) equals
-7i-2E
for
X1
<
X
<
X1+6,
7rWE
for
X2
<
X
<
X2+6,
and 0 elsewhere. Let
?(X)
be the
density
of the random variable
X.
Then,
X
1+8
E
[I2(X)
-
11(X)
]
[I2(X)
-
1I(X)]cp(X)dX
X1
rx2+8
+
1
[I2(X)
-
11(X)]dX
Y2
rXl+8 r
X24-S
=(-72E)
J
(X)dX + (WiE) j
p(X)dX
1
X2
= -
(w2E)7rl
+
(lriE)r2
=
0,
so
that
the
two
policies have the same actuarial
value and, by assumption,
the same
premium.
Define
Y2(X)
in
terms of
12(X) by (1).
Then
Y2(X)
-
Y1(X)
=
12(X)
-11(X).
From
(7),
(8) Y1(X') < Y2(X') < Y2(X)
< Y1(X)
for
X2<X'<?X2+6, X1<X<X1+s.
Since
Y1(X)- Y2(X)
=0
outside
the
intervals
(X1,
X1+5),
(X2,
X2+6),
we
ARROW:
UNCERTAINTY
AND MEDICAL
CARE
971
can
write,
(9)
E{U[Y2(X)]
-
U[Y1(X)]}
J{U[Y2(x)]
-
u[Y,(x)]}I(x)dx
X1
rx2+5
+
1
{U
[y2(X)]
-
U[yl(x)])}
(X)dX.
X2
By
the
Mean
Value
Theorem, for any
given value of X,
(10)
U[y2(X)]
-
U[y1(X)]=
U'[Y(X)][y2(X)
-
Y1(X)]
u
U'
[Y(X)
]
[I2(X)- I1(X)].
where Y(X)
lies between
Y1(X) and
Y2(X). From (8),
Y(X') <
Y(X) for
X2
<
X'
<
X2
+
6,
X1
<
X X1
+
a,
and, since
U'(y) is a
diminishing function
of y for a
risk-averter,
u'
[Y(X')] >
U'[Y(X)]
or,
equivalently, for some
number u,
(11)
U'[Y(X')]>u
for
X2
<
X'
<
X2
+ 6,
U'[Y(X)] < u
for
X1
<
X
<
X1
+
.
Now
substitute (10) into
(9),
E
{
U
[
Y2(X)]
U
[
Y1(X)]}
=
7r2E
u
[Y(X)]O(X)dX
1
rX2+8
+
7rWE
U'
[Y(X)]O(X)dX
X2
From (11),
it
follows that,
E
{
U
[
Y2(X)
]-
U
[
Y1(x) ]}
>
-
7r2EUrl +
rlEU7r2
=
0,
so that the
second
policy
is
preferred.
It
has thus
been shown
that a policy
cannot be
optimal if, for some
Xi
and
X2, I(X1)
>0, Y(X1) >
Y(X2).
This
may
be
put
in
a
different
form: Let
Y1,i.
be
the
minimum
value
taken on by
Y(X) under
the optimal
policy;
then
we
must
have
I(X)
=
0
if
Y(X)> Ymin.
In
other
words,
a minimum
final wealth
level
is
set; if
the loss
would not bring
wealth below
this
level,
no benefit
is
paid,
but if it
would,
then the
benefit
is
sufficient
to
bring up
the final
wealth
position
to
the
stipulated
minimum.
This
is, of
course,
precisely
a
description
of 100
per
cent
coverage
for loss
above
a
deductible.
We turn
to
the
second
proposition.
It is
now
supposed
that
the
insurance
company,
as
well as the
insured,
is
a
risk-averter;
however,
there are
no
administrative or
other costs
to
be
covered
beyond protection
against
loss.
Proposition
2.
If
the
insured and the
insurer
are
both risk-averters
and
there are no
costs other
than
coverage
of
losses,
then
any nontrivial
Pareto-
972
THE
AMERICAN
ECONOMIC
REVIEW
optimal
policy,
I(X), as a
function
of
the
loss,
X,
must
have
the
property,
O
<
dI/dX <
1.
That
is,
any
increment in
loss
will
be
partly
but
not
wholly
compensated
by
the
insurance
company; this
type
of
provision
is
known as
coinsurance.
Proposition 2
is
due
to
Borch
[9,
Sec.
2]; we
give
here
a
somewhat
simpler
proof.
Proof: Let
U(y)
be
the
utility
function of the
insured,
V(z)
that
of
the
insurer.
Let
W0
and
W1
be
the
initial
wealths
of
the
two,
respectively.
In
this
case,
we let
I(X)
be the
insurance
benefits less
the
premium; for the
present
purpose,
this
is
the
only
significant
magnitude
(since
the
premium
is
independent
of X,
this
definition
does
not
change
the
value
of
dI/dX).
The
final
wealth
positions of
the
insured
and insurer are:
(12)
Y(X)
=
wo
-
X
+
I(X),
Z(X)
=
T
-
1(X),
respectively.
Any
given
insurance
policy
then
defines
expected
utilities,
u=Et
U[Y(X)]}
and
v=Et
V[Z(X)]},
for
the
insured and
insurer,
respec-
tively.
If
we
plot
all
points
(u, v)
obtained
by
considering
all
possible
insur-
ance
policies,
the
resulting
expected-utility-possibility
set has
a
boundary
that is
convex
to the
northeast. To
see
this,
let
11(X)
and
I2(X)
be
any
two
policies,
and let
(X1,
v1)
and
(u2,
v2)
be the
corresponding points
in
the
two-
dimensional
expected-utility-possibility
set.
Let a
third
insurance
policy,
I(X),
be
defined
as
the
average
of
the
two
given
ones,
I(X)
=
(21)Il(X)
+
(1)I2(X),
for
each
X.
Then,
if
Y(X),
Y1(X),
and
Y2(X)
are the
final wealth
positions
of the
insured,
and
Z(X),
Z1(X), and
Z2(X)
those
of the insurer
for each
of
the
three
policies,
I(X),
I1(X),
and
I2(X),
respectively,
Y(X)
(2)Y1(X)
+
(2)Y2(X),
Z(X)
(2)Z1(X)
+
(G)Z2(X),
and, because
both
parties
have
diminishing
marginal
utility,
U[Y(X)]
>
(21)U[YI1(X)]
+
(21)U[Y2(X)],
V[Z(X)]
>
(2)V[Z1(X)]
+
(21)V[Z2(X)].
Since
these
statements
hold for all
X,
they
also hold
when
expectations
are
taken.
Hence,
there
is a
point
(u,
v) in the
expected-utility-possibility
set
for
which
u>?(2)U1+(2)U2,
v?>(2)v1+(2)v2.
Since
this
statement
holds for
every pair of
points
(u,,
yi)
and
(u2, v2)
in the
expected-utility-possibility
set,
and
in
particular
for
pairs of
points
on
the
northeast
boundary,
it
fol-
lows
that
the
boundary
must
be
convex
to
the
northeast.
From
this, in
turn, it
follows
that
any
given
Pareto-optimal
point
(i.e.,
any
point oIn
the
northeast
boundary)
can
be
obtained
by
maximizing
a
linear
function,
au+fv,
with
suitably
chosen
a
and
,B
nonnegative
and at
least
one
positive,
over
the
expected-utility-possibility
set.
In
other
words,
a
Pareto-optimal
insurance
policy,
I(X),
is
one which
maximizes,
aE{U[Y(X)]}
+
0E{V[Z(X)]}
-E{laU[Y(X)]
+
0V[Z(X)]},
ARROW:
UNCERTAINTY
AND
MEDICAL CARE
973
for some
a?
>
O,
>
0,
a
>
0
or
/
> 0.
To maximize
this
expectation,
it
is
obvi-
ously
sufficient
to maximize:
(13)
alU[Y(X)]
+
/3v[Z(X)],
with
respect to
I(X),
for
each
X.
Since, for
given
X, it follows
from
(12)
that,
dY(X)/dI(X)
-1,
dZ(X)/dI(X)
-
1,
it
follows
by
differentiation
of
(13)
that
E(X)
is the
solution
of th-ie
equation,
(14)
aU'[Y(X)]
-
OV'[Z(X)]
= 0.
The
cases
a
0
or
,B=0
lead
to
obvious
trivialities (olne
party
simply
hands
over
all
his
wealth
to the
other),
so
we
assume
a
>O,
/3>0.
Now
differentiate
(14)
with
respect
to X
and
use
the
relations,
derived
from
(12),
dY/dX
-
(dI/dX)
-
1
dZ/dX=
-
(dI/dX).
a
U
Y(X)
l(dI/dX)
-
11
+
/3V"[Z
(X)
j
(dI/dX)
=
0,
or
dI/dX
=
aU"
[Y(X)
/{aU"
[Y(X)j
+
f3V"
[Z(X)]}.
Since
U"[Y(X)]<0,
V"[Z(X)]<0
by
the
hypothesis
that both
parties
are
risk-averters,
Proposition,. 2
follows.

Discussion

As mentioned in this paragraph, "a great many risks are not covered", so the risk-bearing of medical care is "nonmarketable" in the sense that it's not simple to buy or sell risk. There are many non-market social institutions and also market institutions (examples like WebMD and ZocDoc ) that attempt to bridge the gap caused by imperfect competitive medical care markets. A pareto optimal allocation is an allocation of resources in which it is impossible to make any one individual better off without making at least one individual worse off. The term is named after Vilfredo Pareto, an Italian engineer and economist, who used the concept in his studies of economic efficiency and income distribution. It is possible for there to be many different pareto optimal allocations. Here Arrow predicts the concept of value-based care. Increasing returns in production is the opposite of diminishing returns in production and basically means that as a firm gets bigger, it becomes more productive. In the insurance industry, bigger companies can have an advantage over small ones because they can spread out risk more (i.e. will be less likely to go into bankruptcy). As we can see, increasing returns complicates the competitive model and in a world with very large companies that have a competitive advantage because of their size, it is possible to dominate markets and reduce competition. The Second Optimality Theorem basically says that if you're unsatisfied with what the economy is producing, you can fix it by redistributing wealth. Arrow also states later on that redistributing wealth is politically difficult, which it still is to this day. Arrow says that you don't have to regulate markets. The assumptions needed for the second optimality theorem come from the 1st optimality theorem. The divergence between private and social costs/benefits relates to the concept of externalities. An externality is defined as "a side effect or consequence of an industrial or commercial activity that affects other parties without this being reflected in the cost of the goods or services involved, such as the pollination of surrounding crops by bees kept for honey." In this case, externalities are discussed in the context of the spread of diseases. By marketability, Arrow means something that you can buy or sell and by commodity, Arrow means anything that is marketable. In 2016, of the 4,926 community hospitals in the US, 20% were state/local government hospitals, 21% were investor-owned for-profit hospitals and 58% were non-profit hospitals. Many non-profit hospitals in the US make significant profits; in 2013 for example, 7 of the the 10 most profitable hospitals were non-profit hospitals. Most of the medical care that we buy from physicians is information in the form of advice (there are more traditional commoditized forms of medical care like surgery). It is very difficult to evaluate the advice we're given by doctors because of the asymmetry of information-> the doctor knows something that the patient does not know. In fact, this is a problem with purchasing any kind of information and it leads to consumer sovereignty failing. This is Kenneth Arrow's most-cited article. He won the Nobel Prize for establishing mathematically, the necessary prerequisites for a free market to have optimal outcomes- that is what "welfare economics" in the title means, it doesn't have anything to do with public assistance. Although there is a lot of regulation in place to monitor how doctors/medical care providers advertise, there is more price competition today than when this article was written and some degree of advertising is possible. (2) still holds true today. (3) was important in Arrow's time and is important today, but the caveat is that today with managed care, the financial incentive has changed from doing too much to not enough Kenneth Arrow is is an American economist, writer, and political theorist. He won the Nobel Memorial Prize in Economics with John Hicks in 1972. At 51, he is the youngest person to have received the award. In economics, he is a major figure in post-World War II neo-classical economic theory. His most significant works are his contributions to social choice theory, notably "Arrow's impossibility theorem” and his work on general equilibrium analysis. He has also provided foundational work in many other areas of economics, including endogenous growth theory and the economics of information. Arrow is uncle to economist and former Treasury Secretary and Harvard President Larry Summers, and brother-in-law of the late economists Robert Summers and Paul Samuelson. The Arrow impossibility theorem states that when voters have three or more distinct alternatives (options), no ranked order voting system can convert the ranked preferences of individuals into a community-wide (complete and transitive) ranking while also meeting a pre-specified set of criteria, unrestricted domain, non-dictatorship, Pareto efficiency, and independence of irrelevant alternatives.